“…The growth of scientific research with psychedelics, which has been called the "Psychedelic Renaissance" (Carhart-Harris, et al, 2018), has become evident during the last years. Contemporary research with psychedelics applied together with new theoretical-methodological approaches, shows therapeutic efficacy and few adverse side effects on a wide variety of neuropsychiatric disorders, namely: drug addiction (Johnson, et al, 2014;Bogenschutz, et al, 2015), post-traumatic stress disorder (PTSD) (Mithoefer, et al, 2019;Schenberg, et al, 2020;Mitchell, et al, 2021), anxiety disorders (Grob, et al, 2010;Gasser, et al, 2014;Danforth, et al, 2016) and depression (Carthart-Harris, et al, 2016;Ross, et al, 2016). Currently, institutions in several countries have gained legal status to carry out clinical-investigative work on the therapeutic potential of psychedelic drugs.…”